Viromed Medical AG

Research Viromed Medical AG (Q11) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

• TickerQ11
• ExchangeHM
• CurrencyEUR
• Financial periodQ3 2025
• RevenueEUR 12.84M
• Net income-EUR 5.31M
• Free cash flow-EUR 30.34M
• Gross margin46.2%